Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Current Assets (2020 - 2026)

NeuroPace has reported Current Assets over the past 7 years, most recently at $87.0 million for Q1 2026.

  • For Q1 2026, Current Assets fell 10.77% year-over-year to $87.0 million; the TTM value through Mar 2026 reached $87.0 million, down 10.77%, while the annual FY2025 figure was $94.1 million, 15.66% up from the prior year.
  • Current Assets for Q1 2026 was $87.0 million at NeuroPace, down from $94.1 million in the prior quarter.
  • Over five years, Current Assets peaked at $122.4 million in Q1 2022 and troughed at $80.2 million in Q2 2024.
  • A 5-year average of $93.3 million and a median of $92.7 million in 2023 define the central range for Current Assets.
  • On a YoY basis, Current Assets climbed as much as 159.98% in 2022 and fell as far as 26.43% in 2022.
  • Year by year, Current Assets stood at $97.7 million in 2022, then fell by 5.11% to $92.7 million in 2023, then dropped by 12.27% to $81.3 million in 2024, then increased by 15.66% to $94.1 million in 2025, then fell by 7.54% to $87.0 million in 2026.
  • Business Quant data shows Current Assets for NPCE at $87.0 million in Q1 2026, $94.1 million in Q4 2025, and $95.3 million in Q3 2025.